Jailani, Jernalyn I.

HRN: 20-61-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2023
CEFTRIAXONE 1G (VIAL)
04/04/2023
04/11/2023
IV
550mg
OD
PCAP-C
Waiting Final Action 
04/09/2023
MUPIROCIN 2%, 15G (TUBE)
04/09/2023
04/15/2023
TOPICAL
2ml
BID
Wound Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: